Cargando…
The plague of unexpected drug recalls and the pandemic of falsified medications in cardiovascular medicine as a threat to patient safety and global public health: A brief review
Valsartan, losartan, and irbesartan, are widely used in the treatment strategies of cardiovascular medicine diseases, including hypertension and heart failure. Recently, many formulations for the aforementioned diseases contained active pharmaceutical ingredients and had been abruptly recalled from...
Autores principales: | Świeczkowski, Damian, Zdanowski, Szymon, Merks, Piotr, Szarpak, Łukasz, Vaillancourt, Régis, Jaguszewski, Miłosz J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890415/ https://www.ncbi.nlm.nih.gov/pubmed/33346374 http://dx.doi.org/10.5603/CJ.a2020.0168 |
Ejemplares similares
-
Falsified Drugs in the Opinion of Patients Diagnosed with Cardiovascular Diseases—Nationwide and Cross-Sectional Study on the Example of EU-Member Country
por: Świeczkowski, Damian, et al.
Publicado: (2021) -
Awareness of the implementation of the Falsified Medicines Directive among pharmaceutical companies’ professionals in the European Economic Area
por: WŁodarczak, Urszula, et al.
Publicado: (2017) -
The European Falsified Medicines Directive in Poland: background, implementation and potential recommendations for pharmacists
por: Merks, Piotr, et al.
Publicado: (2018) -
Pilot Implementation of Falsified Medicines Directive in Hospital Pharmacy to Develop Best Practices for Medicine Decommissioning Process
por: Merks, Piotr, et al.
Publicado: (2020) -
Patient counselling service with the use of pictograms as the example of pharmacist intervention to improving compliance and medicine safety
por: Merks, Piotr, et al.
Publicado: (2021)